Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02362009 · ClinicalTrials.gov registry record
South Miami Hospital Fibroid Registry
A clinical trial, sponsored by Baptist Health South Florida.
- Terminated
- Registry status
- 52
- Enrollment target
NCT02362009: Clinical Trial study, sponsored by Baptist Health South Florida.
NCT02362009 is a clinical trial that was terminated before completion, run by Baptist Health South Florida. The registered enrollment target is 52 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02362009 was terminated before completion, sponsored by Baptist Health South Florida.
- TERMINATED
- Registry status
- 52 participants
- Enrollment target
Study Summary
The purpose of the Fibroid Registry is to provide a comprehensive database that captures patient characteristics, clinical outcomes and pot-treatment quality of life measures for patients treated for uterine fibroids. This database will serve as a platform for future comparative effectiveness and other health services research studies.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2015-02 |
| Est. Completion | 2015-12 |
Why NCT02362009 stopped before completion
NCT02362009 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 52 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02362009 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02362009 about?
NCT02362009 is a clinical study titled "South Miami Hospital Fibroid Registry". The purpose of the Fibroid Registry is to provide a comprehensive database that captures patient characteristics, clinical outcomes and pot-treatment quality of life measures for patients treated for uterine fibroids. This database will serve as a platform for future comparative effectiveness and ot...
What is the current status of trial NCT02362009?
This trial is currently terminated. The enrollment target is 52 participants. The study started on 2015-02. Estimated completion is 2015-12.
Who is sponsoring clinical trial NCT02362009?
This trial is sponsored by Baptist Health South Florida, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia